Article Content

INSTRUCTIONS Menopause: A primary care perspective



* Read the article. The test for this CE activity is to be taken online at Tests can no longer be mailed or faxed.


* You'll need to create (it's free!) and log in to your personal CE Planner account before taking online tests. Your planner will keep track of all your Lippincott Professional Development online CE activities for you.


* There's only one correct answer for each question. A passing score for this test is 7 correct answers. If you pass, you can print your certificate of earned contact hours and access the answer key. If you fail, you have the option of taking the test again at no additional cost.


* For questions, contact Lippincott Professional Development: 1-800-787-8985.


* Registration deadline is December 6, 2024.



Lippincott Professional Development will award 2.0 contact hours and 1.0 pharmacology consult hour for this continuing nursing education activity.


Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.0 contact hours. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, and Florida, CE Broker #50-1223. Your certificate is valid in all states.


Payment: The registration fee for this test is $21.95


Menopause: A primary care perspective


Learning Outcomes: Seventy-five percent of participants will be able to demonstrate a gain in knowledge of primary care menopause management by achieving a posttest score of 70% or greater.


Learning Objectives: After reading the article and completing the posttest, the participant will be able to:


1. Recognize the physiology of menopause.


2. Apply diagnostic principles to women with amenorrhea for 12 months.


3. Select pharmacologic and nonpharmacologic options for the management of a patient with symptoms related to menopause.


4. Identify osteoporosis and breast cancer risk assessments and concerns for menopausal women.





1. The most significant change during the menopausal process, along with declining follicular function, is the reduction in circulating


a. estrone.


b. estradiol.


c. FSH and LH.


2. The differential diagnosis for a 43-year-old woman with amenorrhea for 12 months includes all of the following except


a. anemia.


b. thyroid disease.


c. hyperprolactinemia.


3. Which antidepressant has been approved by the FDA as an effective treatment for hot flash symptoms?


a. venlafaxine (Effexor)


b. citalopram (Celexa)


c. paroxetine (Brisdelle)Case-Based Assessment: Placing yourself in the role of the NP, use the scenario below to apply knowledge and skills learned in the attached article.Questions #4 - #10 are based on the following Case Scenario:LT is a 48-year-old woman with a body mass index of 23.4 and no recent weight loss. She presents with a chief complaint of hot flashes and reports that her symptoms cause her to awaken at least twice each night. LT's past medical history is significant for hypertriglyceridemia and a seizure disorder that is well-controlled with phenytoin. She also has a cigarette smoking history of 10 years.


4. Which of the following is the recommended criterion to use for diagnosing menopause in this patient?


a. a measurement of FSH


b. the level of anti-Mullerian hormone


c. amenorrhea for 12 months


5. As identified in the article, a lifestyle modification that you would recommend to help LT in managing her hot flashes is


a. taking black cohosh.


b. cigarette smoking cessation.


c. cognitive behavioral therapy.


6. Because of the severity of LT's hot flashes, you are considering initiating estrogen-progestin therapy for her. Taking her medical history and medication use into account, what would be the preferred route of estrogen administration?


a. transdermal


b. topical


c. oral


7. Patient education for LT that is related to taking exogenous estrogen includes


a. starting isoflavone supplementation.


b. adding phytoestrogens.


c. limiting alcohol intake.


8. In addition to pharmaceutical estrogen therapy, what would be an appropriate recommendation for LT to improve her sleep?


a. avoid massages


b. reduce stress


c. stop exercising


9. Starting LT with MHT near the time of her menopause may place her at a greater risk for developing


a. colon cancer.


b. breast cancer.


c. lung cancer.


10. Using validated assessment tools such as FRAX(R) is critically important for assessing LT's risk of


a. fracture.


b. diabetes.


c. colon cancer.